Klinikum der Universität München-Großhadern

München, Bavaria 81377

0 studies enrolling now · 4 studies all time

What they study most

Chronic Idiopathic Constipation, Medullary Thyroid Cancer, Soft Tissue Sarcoma, Systemic Lupus Erythematosus

Studies at this site

• A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer — Running, not enrolling
• A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma — Completed
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) — Stopped early
• 26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation — Stopped early